Literature DB >> 26581005

HABP2 Mutation and Nonmedullary Thyroid Cancer.

Jerneja Tomsic, Huiling He, Albert de la Chapelle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26581005     DOI： 10.1056/NEJMc1511631

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  10 in total

1.  RE: HABP2 G534E Mutation in Familial Nonmedullary Thyroid Cancer.

Authors:  Luis G Carvajal-Carmona; Ian Tomlinson; Ruta Sahasrabudhe
Journal:  J Natl Cancer Inst       Date:  2016-05-06       Impact factor: 13.506

2.  G534E Variant in HABP2 and Nonmedullary Thyroid Cancer.

Authors:  Macarena Ruiz-Ferrer; Raquel M Fernández; Elena Navarro; Guillermo Antiñolo; Salud Borrego
Journal:  Thyroid       Date:  2016-07       Impact factor: 6.568

3.  Germline Mutations in Familial Papillary Thyroid Cancer.

Authors:  Marta Sarquis; Debora C Moraes; Luciana Bastos-Rodrigues; Pedro G Azevedo; Adauto V Ramos; Fabiana Versiani Reis; Paula V Dande; Isabela Paim; Eitan Friedman; Luiz De Marco
Journal:  Endocr Pathol       Date:  2020-03       Impact factor: 3.943

4.  HABP2 germline variants are uncommon in familial nonmedullary thyroid cancer.

Authors:  Alexia L Weeks; Scott G Wilson; Lynley Ward; Jack Goldblatt; Jennie Hui; John P Walsh
Journal:  BMC Med Genet       Date:  2016-08-17       Impact factor: 2.103

5.  The p.G534E variant of HABP2 is not associated with sporadic papillary thyroid carcinoma in a Polish population.

Authors:  Artur Kowalik; Danuta Gąsior-Perczak; Martyna Gromek; Monika Siołek; Agnieszka Walczyk; Iwona Pałyga; Małgorzata Chłopek; Janusz Kopczyński; Ryszard Mężyk; Aldona Kowalska; Stanisław Góźdź
Journal:  Oncotarget       Date:  2017-04-06

6.  HABP2 p.G534E variant in patients with family history of thyroid and breast cancer.

Authors:  Maisa Pinheiro; Sandra Aparecida Drigo; Renata Tonhosolo; Sonia C S Andrade; Fabio Albuquerque Marchi; Igor Jurisica; Luiz Paulo Kowalski; Maria Isabel Achatz; Silvia Regina Rogatto
Journal:  Oncotarget       Date:  2017-06-20

Review 7.  Genetic susceptibility to hereditary non-medullary thyroid cancer.

Authors:  Tina Kamani; Parsa Charkhchi; Afshan Zahedi; Mohammad R Akbari
Journal:  Hered Cancer Clin Pract       Date:  2022-03-07       Impact factor: 2.857

8.  The HABP2 G534E polymorphism does not increase nonmedullary thyroid cancer risk in Hispanics.

Authors:  Mabel E Bohórquez; Ana P Estrada; Jacob Stultz; Ruta Sahasrabudhe; John Williamson; Paul Lott; Carlos S Duque; Jorge Donado; Gilbert Mateus; Fernando Bolaños; Alejandro Vélez; Magdalena Echeverry; Luis G Carvajal-Carmona
Journal:  Endocr Connect       Date:  2016-04-20       Impact factor: 3.335

9.  Pitfalls of exome sequencing: a case study of the attribution of HABP2 rs7080536 in familial non-medullary thyroid cancer.

Authors:  Glenn S Gerhard; Darrin V Bann; James Broach; David Goldenberg
Journal:  NPJ Genom Med       Date:  2017-03-28       Impact factor: 8.617

Review 10.  Genetic Mutations and Variants in the Susceptibility of Familial Non-Medullary Thyroid Cancer.

Authors:  Fabíola Yukiko Miasaki; Cesar Seigi Fuziwara; Gisah Amaral de Carvalho; Edna Teruko Kimura
Journal:  Genes (Basel)       Date:  2020-11-18       Impact factor: 4.096
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.